Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target
Hua Wang(Chinese Academy of Sciences), Hongbin Ji(ShanghaiTech University), Kwok‐Kin Wong(Brigham and Women's Hospital), Qibiao Wu(Macau University of Science and Technology), Xinyuan Tong(Shanghai Jiao Tong University), Chenchen Guo(Chinese Academy of Sciences), Shijie Tang(Chinese Academy of Sciences), Weikang Zhu(Chinese Academy of Sciences), Shun Yao(Chinese Academy of Sciences), Yayi He(Tongji University), Cai‐Guang Yang(Shanghai Jiao Tong University), Xinyun Xie(Chinese Academy of Sciences), Shuo Han(Chinese Academy of Sciences), Zhen Qin(Chinese Academy of Sciences), Xiaoling Xu(Tongji University), Yueh‐Hung Chou(Far Eastern Memorial Hospital), Shiyu Zhou(Chinese Academy of Sciences), Xue Wang(Chinese Academy of Sciences), Yong Wang(Chinese Academy of Sciences), Liang Hu(Chinese Academy of Sciences), Luonan Chen(ShanghaiTech University)
Cited by 7
Related Papers
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
|Clinical Cancer Research|2018|445
Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis
|Signal Transduction and Targeted Therapy|2020|429
Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
|Cancer Research|2021|280